
Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …

Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

